Preview Mode Links will not work in preview mode

Jun 28, 2022

Featuring perspectives from Drs Javier Cortés, Matthew Goetz, Erika Hamilton, Ian Krop, Hope Rugo and Sara Tolaney, including the following topics:

  • Introduction (0:00)
  • Optimizing the Management of ER-Positive Localized Breast Cancer — Matthew P Goetz, MD (7:50)
  • New and Novel Treatment Strategies for...


May 17, 2022

Featuring perspectives from Ms Jamie Carroll, Dr Sara Hurvitz, Ms Kelly Leonard and Dr Hope Rugo, including the following topics:

  • Introduction (0:00)
  • High-Risk Localized ER-Positive, HER2-Negative Breast Cancer (5:07)
  • ER-Positive Metastatic Breast Cancer (28:06)
  • Localized HER2-Positive Breast Cancer (49:15)
  • Metastatic...


Apr 20, 2022

Featuring a slide presentation and related discussion from Dr Judy Garber, including the following topics:

  • PARP Inhibitors in Breast Cancer (0:00)
  • OlympiA and NEOTALA Trials (12:03)
  • Emerging Strategies with PARP Inhibitors in Breast Cancer (20:08)

CME information and select...


Apr 20, 2022

Featuring an interview with Dr Judy Garber, including the following topics:

  • Applying the FDA indications for PARP inhibitors in breast cancer (0:00)
  • Role of HRD (homologous recombination deficiency) and loss of heterozygosity in assessing patient risk; potential role for PARP inhibitors and other therapies for patients...


Mar 16, 2022

The Great Adjuvant Debate — Exploring the Role of Novel Therapies in the Management of Localized Cancer — Faculty Presentation 3: Optimal Integration of Novel Therapies in the Management of Localized Breast Cancer — Dr Sara Tolaney

CME information and select...